Hui-qiang Zhou

发表

Discovery of Pyrazolocarboxamides as Potent and Selective Receptor Interacting Protein 2 (RIP2) Kinase Inhibitors.

Joseph P. Romano, N. C. Goodwin, J. Bertin, 2019, ACS medicinal chemistry letters.

Synthesis and SAR of Benzisothiazole- and Indolizine-β-d-glucopyranoside Inhibitors of SGLT2.

Chari D Smith, S. Roller, D. Danger, 2010, ACS medicinal chemistry letters.

Melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity.

Hui-qiang Zhou, A. L. Handlon, 2006, Journal of medicinal chemistry.

Novel pyrazolopyrimidine derivatives as GSK-3 inhibitors.

S. A. Thomson, J. Boucheron, A. Peat, 2004, Bioorganic & medicinal chemistry letters.

Spiropentylacetyl-CoA, A Mechanism-Based Inactivator of Acyl-CoA Dehydrogenases

Hung‐wen Liu, I. Shin, S. Dakoji, 1998 .

Characterization of a unique coenzyme B6 radical in the ascarylose biosynthetic pathway [14]

G. H. Reed, Hung‐wen Liu, V. Bandarian, 2000 .

3-DEOXY-3-FLUOROPYRIDOXAMINE 5'-PHOSPHATE: SYNTHESIS AND CHEMICAL AND BIOLOGICAL PROPERTIES OF A COENZYME B6 ANALOG

Ding-Yah Yang, Hung‐wen Liu, Hui-qiang Zhou, 1997 .

The discovery and optimization of pyrimidinone-containing MCH R1 antagonists.

M. J. Bishop, A. Goetz, F. Tavares, 2006, Bioorganic & medicinal chemistry letters.

Biological activity of (3R,5S,6R)- and (3S,5R,6S)-3,5-dimethyl-6-(methylethyl)-3,4,5,6-tetrahydropyran-2-one, a pheromone ofMacrocentrus grandii (Goidanich) (Hymenoptera: Braconidae)

Hung‐wen Liu, I. Shin, Richard L. Jones, 1994, Journal of Chemical Ecology.

A Sex Pheromone Isolated from Macrocentrus grandii. Absolute Stereochemistry Determination and Implications

Hung‐wen Liu, I. Shin, Richard L. Jones, 1993 .

Potent, selective, and orally efficacious antagonists of melanin-concentrating hormone receptor 1.

M. J. Bishop, A. Goetz, F. Tavares, 2006, Journal of medicinal chemistry.

N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as potent and selective inhibitors of glycogen synthase kinase 3 with good cellular efficacy.

R. Griffin, F. Tavares, S. A. Thomson, 2004, Journal of medicinal chemistry.

6-(4-chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-based melanin-concentrating hormone receptor 1 antagonist.

M. J. Bishop, A. Goetz, F. Tavares, 2006, Journal of medicinal chemistry.

Potent and selective ketoamide-based inhibitors of cysteine protease, cathepsin K.

F. Tavares, Aaron B. Miller, D. N. Deaton, 2004, Journal of medicinal chemistry.

Orally bioavailable small molecule ketoamide-based inhibitors of cathepsin K.

K. Wells-Knecht, F. Tavares, D. N. Deaton, 2004, Bioorganic & medicinal chemistry letters.

Identification of nonabsorbable inhibitors of the scavenger receptor-BI (SR-BI) for tissue-specific administration.

J. Parham, S. M. Sparks, C. Jayawickreme, 2016, Bioorganic & medicinal chemistry letters.

Application of phosphoramidate ProTide technology significantly improves antiviral potency of carbocyclic adenosine derivatives.

T. Burnette, J. Balzarini, C. Mcguigan, 2006, Journal of medicinal chemistry.

P2-P3 conformationally constrained ketoamide-based inhibitors of cathepsin K.

J. A. Ray, L. Shewchuk, A. Hassell, 2005, Bioorganic & medicinal chemistry letters.

Melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity.

Hui-qiang Zhou, A. L. Handlon, 2006, Journal of medicinal chemistry.

Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k.

L. Shewchuk, A. Hassell, K. Wells-Knecht, 2004, Journal of medicinal chemistry.